Medicare Enrolled
Dr. Robert Haverly, M.D.
Ophthalmology · Erie, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Haverly from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Haverly?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Haverly
Dr. Robert Haverly is an ophthalmology specialist in Erie, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Haverly performed 18,850 Medicare services across 4,338 unique beneficiaries.
Between the years covered by Open Payments, Dr. Haverly received a total of $10,611 from 31 pharmaceutical and/or device companies across 131 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Haverly is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 5% volume in PA
$10,611 industry payments
Medicare Practice Summary
Medicare Utilization ↗18,850
Medicare services
Top 5% in PA for ophthalmology
4,338
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~942 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) An injection of faricimab-svoa, a medication administered in 0.1 mg doses. |
10,800 | $28 | $60 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
2,583 | $26 | $160 |
| Injection, ranibizumab, 0.1 mg | 1,454 | $179 | $484 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
902 | $53 | $100 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
513 | $82 | $250 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
369 | $39 | $100 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
359 | $93 | $160 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
280 | $21 | $160 |
| Laser removal of recurring cataract A laser procedure to remove a recurring cataract within the lens capsule. |
254 | $240 | $980 |
| Cataract surgery with lens implant Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision. |
188 | $341 | $1,200 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
183 | $73 | $140 |
| Corneal topography and eye depth measurement This procedure measures the curvature and depth of the cornea, the clear front surface of the eye. |
180 | $27 | $235 |
| Complex cataract removal with lens implant A surgical procedure to remove a cataract from the eye and insert an artificial lens to restore vision. |
139 | $486 | $1,994 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
136 | $51 | $110 |
| Eye drainage system examination An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye. |
119 | $17 | $65 |
| Ultrasound scan of cornea to determine thickness An ultrasound procedure used to measure the thickness of the cornea. |
56 | $7 | $50 |
| Incision to improve eye fluid flow A surgical procedure involving an incision to enhance the drainage of fluid within the eye. |
55 | $615 | $1,625 |
| Retinal laser destruction of growth A laser procedure used to destroy abnormal growths in the retina. |
47 | $380 | $1,380 |
| Retinal angiography with dye injection This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body. |
47 | $93 | $281 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
41 | $25 | $75 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
36 | $76 | $127 |
| Laser repair to improve eye fluid flow A laser procedure used to enhance the drainage of fluid within the eye. |
29 | $161 | $1,250 |
| Tear duct plug insertion A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface. |
24 | $124 | $300 |
| Amniotic membrane placement on eye surface This procedure involves placing amniotic membrane on the surface of the eye to promote wound healing. |
22 | $979 | $1,700 |
| Imaging of front third of eye Imaging of the front third of the eye. |
19 | $18 | $75 |
| Extended eye exam with retinal drawing A detailed examination of the back of the eye that includes creating a drawing of the retina. |
15 | $19 | $85 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.0% high complexity
83.6% medium
15.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,611
Total received (2018-2024)
Avg $1,516/year across 7 years
Top 11% in PA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
131
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Other
Charitable contributions, space rental, and other categories
$7,493 (70.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,038 (28.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$80 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,180
2023
$639
2022
$401
2021
$321
2020
$148
2019
$478
2018
$445
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Glaukos Corporation
$7,493
Apellis Pharmaceuticals, Inc.
$188
NEW WORLD MEDICAL,INC.
$117
Regeneron Healthcare Solutions, Inc.
$108
Genentech USA, Inc.
$87
Alcon Vision LLC
$81
ABBVIE INC.
$70
Sight Sciences, Inc.
$36
Top 3 companies account for 95.3% of 2024 payments
All-time payments by company (2018-2024) ›
Glaukos Corporation
$7,696
Genentech USA, Inc.
$521
Apellis Pharmaceuticals, Inc.
$363
Alcon Vision LLC
$298
NEW WORLD MEDICAL,INC.
$236
Oyster Point Pharma, Inc.
$173
Alcon Laboratories Inc
$139
Shire North American Group Inc
$138
Dompe US, Inc.
$125
Allergan, Inc.
$108
Regeneron Healthcare Solutions, Inc.
$108
ABBVIE INC.
$70
Novartis Pharmaceuticals Corporation
$58
Carl Zeiss Meditec, Inc.
$58
Eyevance Pharmaceuticals LLC
$54
TissueTech, Inc.
$51
Johnson & Johnson Surgical Vision, Inc.
$42
Aerie Pharmaceuticals, Inc.
$41
Sun Pharmaceutical Industries Inc.
$41
Bausch & Lomb, a division of Bausch Health US, LLC
$38
Kala Pharmaceuticals, Inc.
$36
Sight Sciences, Inc.
$36
RxSight Inc
$27
GLAUKOS CORPORATION
$26
Omeros Corporation
$20
Allergan Inc.
$20
Bausch & Lomb Americas Inc.
$20
Astellas Pharma US Inc
$19
TISSUETECH, INC.
$18
Ziemer USA
$17
Alcon Research LLC
$15
Top 3 companies account for 80.9% of all-time payments
Associated products mentioned in payments ›
ACTIVEFOCUS · ARGOS · AcrySof IQ PanOptix · AcrySof IQ VIVITY IOL · Ahmed Glaucoma Valve · BROMSITE · CEQUA · Clareon · CyPass · DURYSTA · EYLEA HD · Flarex · INFUSE · INVELTYS · KXL SYSTEM · KXL System · Kahook Dual Blade · LOTEMAX SM · LUMIGAN · Lucentis · OMNI SURGICAL SYSTEM · OPMI Lumera · OXERVATE · Omidria · PROKERA · PanOptix · Prokera · RXSIGHT CONTACT LENS · ReSTOR · Rhopressa · Rocklatan · SUSVIMO · Simbrinza · Syfovre · TRAVATAN Z · TYRVAYA · Tecnis IOL · Tecnis Multifocal Family of 1-piece IOLS · VABYSMO · VUITY · VYZULTA · Vabysmo · XIIDRA · Z8 · iStent Trabecular Micro-Bypass System Model iS3
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Payments are distributed across multiple categories with no single dominant type.
Geographic Context
Ophthalmologists within 10 mi
20
Per 100K population
7.4
County median income
$61,476
Nearest hospital
UPMC HAMOT
1.8 mi
1.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Haverly is a mixed practice specialist, with above-average Medicare volume (top 5% in PA), with mixed engagement industry engagement in the top 11% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Haverly experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Haverly performed 10,800 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Haverly receive payments from pharmaceutical companies?
Yes. Dr. Haverly received a total of $10,611 from 31 companies across 131 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Haverly's costs compare to other ophthalmologists in Erie?
Dr. Haverly's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Haverly) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Erie
Browse ophthalmologists in Erie ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in PA
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in PA
Which PA ophthalmologists receive the most from drug and device companies.
By company
Glaukos Corporation Payments to Doctors
See all physicians who received payments from Glaukos Corporation.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Apellis Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Apellis Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology